MeSH tree: B04.450
Researchers at the Ruhr University Bochum have developed a novel antiviral concept: Using the CRISPR/Cas13 system, they were able to specifically suppress the replication of the hepatitis E virus in human cells. Hepatitis ...
May 17, 2026
0
4
Millions of people worldwide carry viral infections they acquired at birth, often for life. For a long time it was assumed that the immune system hardly fights these pathogens. Researchers from the University of Basel show ...
Apr 28, 2026
0
11
An international team of researchers has identified a promising new approach for treating infections with the Hepatitis E virus (HEV). At the center of the study is the drug Apilimod, which specifically blocks the entry of ...
Apr 23, 2026
0
3
It took less than 22 years after the discovery of the hepatitis C virus (HCV) for a fast-acting, highly effective treatment to become available. Modern drugs are more than 95% effective at curing hepatitis C infection, yet ...
Apr 20, 2026
0
5
Cats are not just beloved companions; they are emerging as key "research partners" in unraveling viral cancer mechanisms. A team led by Professor Julia Beatty, Chair Professor of Veterinary Medicine and Infectious Diseases ...
Apr 13, 2026
0
40
Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease unfolds in people, from ...
Apr 6, 2026
0
7
Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as a compound ...
Mar 20, 2026
0
6
A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost, according to researchers ...
Jan 2, 2026
0
47
Hepatitis B virus (HBV) infects more than 250 million people worldwide and can lead to chronic liver disease and liver cancer. Current antiviral therapies suppress viral replication but do not eliminate the virus, highlighting ...
Dec 23, 2025
0
17
Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more than 95% of those who complete ...
Dec 22, 2025
0
15
